Show an ad over header. AMP

FDA authorizes Moderna's COVID-19 vaccine for emergency use

The Food and Drug Administration has issued an emergency use authorization (EUA) for Moderna's COVID-19 vaccine, one day after it was endorsed by a panel of independent experts.

Why it matters: The authorization of a second coronavirus vaccine, coming exactly one week after the FDA cleared Pfizer-BioNTech's vaccine for emergency use, marks another milestone on the country’s path to curbing the pandemic and increases access for millions of Americans.

Between the lines: Moderna's vaccine, which the FDA confirmed is safe and has a 94.1% efficacy rate, does not need to be stored at ultracold temperatures and comes in smaller batches, making it easier to distribute to rural areas than Pfizer's vaccine.

What's next: The FDA's decision means that the distribution of roughly 6 million doses of Moderna's vaccine will begin this weekend.

  • The Centers for Disease Control has advised that frontline workers and nursing home patients be the first recipients of available vaccines. Thousands began receiving the first doses of Pfizer's vaccine last week.
  • A CDC committee will decide on Sunday which "priority group" should come next, with "essential workers" like teachers and law enforcement likely to be recommended, according to the New York Times.
  • Governors will then be responsible for determining which people within that group will receive their state's limited supply of vaccines.

The big picture: The authorization of Moderna's vaccine comes one day after a record 3,438 Americans were reported to have died from the virus. It also comes amid confusion and concern after the Trump administration informed state after state that they'll be getting 25%-40% fewer Pfizer vaccine doses next week than they'd been expecting.

What to watch: Operation Warp Speed officials said Johnson & Johnson closed recruitment for its Phase 3 trials — which have enlisted about 44,000 people — on Thursday.

  • The company is expecting results on its one-dose vaccine candidate by early January.

Kellyanne Conway: "Power should be used sparingly yet strategically"

Kellyanne Conway has seen power exercised as a pollster, campaign manager and senior counselor to President Trump. Now that his term in office has concluded, she shared her thoughts with Axios.

Why it matters: If there's a currency in this town, it's power, so we've asked several former Washington power brokers to share their best advice as a new administration and new Congress settle in.

Keep reading... Show less

Pro-Trump reps continue plan to oust Cheney

Pro-Trump holdouts in the House are forging ahead with an uphill campaign to oust Rep. Liz Cheney as head of the chamber's Republican caucus even though Minority Leader Kevin McCarthy told them to back down.

Why it matters: What happens next will be a test of McCarthy's party control and the sincerity of his opposition to the movement. Cheney (R-Wyo.) is seen as a potential leadership rival to the California Republican.

Keep reading... Show less

Democrats aim to punish House Republicans for Capitol riot

House Democrats plan to take advantage of corporate efforts to cut funding for Republicans who opposed certifying the 2020 election results, with a plan to target vulnerable members in the pivotal 2022 midterms for their role in the Jan. 6 violence.

Why it matters: It's unclear whether the Democrats' strategy will manifest itself in ads or earned media in the targeted races or just be a stunt to raise money for themselves. But the Capitol violence will be central to the party's messaging as it seeks to maintain its narrow majorities in Congress.

Keep reading... Show less

Google's parent shuts down effort to deliver Internet via balloons

Alphabet is shutting down Loon, one of its "moonshots" which aimed to deliver Internet service via high-altitude balloons.

Why it matters: The effort was one of several approaches designed to get high-speed connectivity to some of the world's remote spots and also proved useful in the aftermath of disasters that shut down traditional infrastructure.

Keep reading... Show less

What has and hasn't changed as Biden takes over U.S. foreign policy

President Biden swiftly recommitted the U.S. to the Paris climate pact and the World Health Organization, but America's broader foreign policy is in a state of flux between the Trump and Biden eras.

Driving the news: One of the most striking moves from the Biden administration thus far was a show of continuity — concurring with the Trump administration's last-minute determination that China had committed "genocide" against Uyghur Muslims.

Keep reading... Show less

McConnell to propose February impeachment trial

Senate Minority Leader Mitch McConnell (R-Ky.) plans to propose later today that the impeachment trial of former President Trump begin in February to allow for due process, two sources familiar with the proposal tell Axios.

Why it matters: The impeachment trial is likely to grind other Senate business to a halt, including the confirmation process for President Biden's Cabinet nominees.

Keep reading... Show less

Podcast: Net neutrality on the line under Biden

Federal net neutrality rules are back on the table in the Biden administration, after being nixed by Trump, but now might be complicated by the debate over social media companies' behavior.

Axios Re:Cap digs into why net neutrality matters and what comes next with Nilay Patel, editor-in-chief of The Verge and host of the Decoder podcast.

House grants waiver for Biden's Pentagon pick Gen. Lloyd Austin

The House voted 326-78 on Thursday to grant retired Gen. Lloyd Austin a waiver to lead the Pentagon, clearing the way for the Senate to confirm President Biden's nominee for defense secretary as early as this week.

Why it matters: Austin's nomination received pushback from some lawmakers, including Democrats, who cited a law that requires officers be out of the military for at least seven years before taking the job — a statute intended to reinforce the tradition of civilian control of the Pentagon.

Keep reading... Show less



Get Goodhumans in your inbox

Most Read

More Stories